natgillin/translations-raw huggingface dataset:
A transitional period of five years from the entry into force of this Article, during which the use of the above indication shall not be prevented, shall apply to any other persons, including their successors and assignees, who made commercial use of those indications with regard to products in the class of ‘fresh, frozen and processed meats’, for less than five years preceding the date of 18 October 2013.
Skupni odbor CETA, ustanovljen v skladu s členom 26.1 (v nadaljnjem besedilu: Skupni odbor CETA), ki odloča s soglasjem in na priporočilo Odbora CETA o geografskih označbah, se lahko odloči spremeniti Prilogo 20-A, tako da doda geografske označbe ali odstrani tiste, ki v svojem kraju porekla niso več zaščitene ali so se prenehale uporabljati.
Notwithstanding Articles 20.19.2 and 20.19.3, the protection of the geographical indications listed in Part A of Annex 20-A and identified by three asterisks shall not prevent the use of those indications by any persons, including their successors and assignees, who made commercial use of those indications with regard to products in the classes of ‘dry-cured meats’ and ‘cheeses’, respectively, for at least ten years preceding the date of 18 October 2013.
Geografska označba se načeloma ne doda v del A Priloge 20-A, če je označba ime, ki je na datum podpisa tega sporazuma vključeno v ustrezni register Evropske unije s statusom „Registrirano“ v zvezi z državo članico Evropske unije.
A transitional period of five years from the entry into force of this Article, during which the use of the above indications shall not be prevented, shall apply to any other persons, including their successors and assignees, who made commercial use of those indications with regard to products in the class of ‘dry-cured meats’ and ‘cheeses’, respectively, for less than ten years preceding the date of 18 October 2013.
Geografska označba, ki določa proizvod s poreklom iz določene pogodbenice, se ne doda v Prilogo 20-A:
If a trademark has been applied for or registered in good faith, or if rights to a trademark have been acquired through use in good faith, in a Party before the applicable date set out in paragraph 6, measures adopted to implement this Sub-section in that Party shall not prejudice the eligibility for or the validity of the registration of the trademark, or the right to use the trademark, on the basis that the trademark is identical with, or similar to, a geographical indication.
če je enaka blagovni znamki, ki je bila registrirana v drugi pogodbenici v zvezi z enakim ali podobnim proizvodom, ali blagovni znamki, v zvezi s katero so bile v drugi pogodbenici pravice pridobljene z uporabo v dobro veri in je bil vložen zahtevek v zvezi z enakimi ali podobnimi proizvodi;
For the purposes of paragraph 5 the applicable date is:
če je enaka splošnemu imenu rastlinske ali živalske vrste, ki se uporablja v drugi pogodbenici, ali
in respect of a geographical indication listed in Annex 20-A on the date of signing of this Agreement, the date of coming into force of this Sub-section; or
če je enaka izrazu, ki se v splošnem jeziku običajno uporablja kot splošno ime za tak proizvod v drugi pogodbenici.
in respect of a geographical indication added to Annex 20-A after the date of signing of this Agreement pursuant to Article 20.22, the date on which the geographical indication is added.
Člen 20.23
If a translation of a geographical indication is identical with or contains within it a term customary in common language as the common name for a product in the territory of a Party, or if a geographical indication is not identical with but contains within it such a term, the provisions of this Sub-section shall not prejudice the right of any person to use that term in association with that product in the territory of that Party.
Druga zaščita
Nothing shall prevent the use in the territory of a Party, with respect to any product, of a customary name of a plant variety or an animal breed, existing in the territory of that Party as of the date of entry into force of this Sub-section.
Določbe tega pododdelka ne posegajo v pravico do zahtevka za priznavanje in registracijo geografske označbe v skladu z zadevno zakonodajo pogodbenice.
A Party may provide that any request made under this Sub-section in connection with the use or registration of a trademark must be presented within five years after the adverse use of the protected indication has become generally known in that Party or after the date of registration of the trademark in that Party provided that the trademark has been published by that date, if such date is earlier than the date on which the adverse use became generally known in that Party, provided that the geographical indication is not used or registered in bad faith.
Pododdelek D
The provisions of this Sub-section shall not prejudice the right of any person to use, in the course of trade, that person's name or the name of that person's predecessor in business, except where such name is used in such a manner as to mislead the public.
Vzorci in modeli
The provisions of this Sub-section shall not prejudice the right of any person to use, or to register in Canada a trademark containing or consisting of, any of the terms listed in Part A of Annex 20-B; and
Člen 20.24
Subparagraph (a) does not apply to the terms listed in Part A of Annex 20-B in respect of any use that would mislead the public as to the geographical origin of the goods.
Vsaka pogodbenica si razumno prizadeva za pristop k Ženevskemu aktu Haaškega sporazuma o mednarodni registraciji modelov, sprejetemu 2. julija 1999 v Ženevi.
The use in Canada of the terms listed in Part B of Annex 20-B shall not be subject to the provisions of this Sub-section.
Člen 20.25
An assignment as referred to in paragraphs 2 through 4 does not include the transfer of the right to use a geographical indication on its own.
Povezava z avtorskimi pravicami
Article 20.22
Vsebina pravice v zvezi z vzorci in modeli je lahko zaščitena v okviru prava o avtorskih pravicah, če so izpolnjeni pogoji za to zaščito.
Amendments to Annex 20-A
Obseg take zaščite in pogoje, pod katerimi se odobri, vključno s stopnjo zahtevane izvirnosti, določi vsaka pogodbenica.
The CETA Joint Committee, established under Article 26.1 (The CETA Joint Committee), acting by consensus and on a recommendation by the CETA Committee on Geographical Indications, may decide to amend Annex 20-A by adding geographical indications or by removing geographical indications which have ceased to be protected or have fallen into disuse in their place of origin.
Pododdelek E
A geographical indication shall not in principle be added to Part A of Annex 20-A, if it is a name that on the date of the signing of this Agreement is listed in the relevant Register of the European Union with a status of ‘Registered’, in respect of a Member State of the European Union.
Patenti
A geographical indication identifying a product originating in a particular Party shall not be added to Annex 20-A:
Člen 20.26
if it is identical to a trademark that has been registered in the other Party in respect of the same or similar products, or to a trademark in respect of which in the other Party rights have been acquired through use in good faith and an application has been filed in respect of the same or similar products;
Vsaka pogodbenica si razumno prizadeva za usklajenost s členi 1 do 14 in členom 22 Pogodbe o patentnem pravu, sklenjene 1. junija 2000 v Ženevi.
if it is identical to the customary name of a plant variety or an animal breed existing in the other Party; or
Člen 20.27
if it is identical with the term customary in common language as the common name for such product in the other Party.
Zaščita sui generis za zdravila
Article 20.23
osnovni patent pomeni patent, ki ščiti izdelek kot tak, proces za pridobitev izdelka ali uporabo izdelka in ki ga je imetnik patenta, ki se lahko uporablja za osnovni patent, določil za osnovni patent za namene dodelitve zaščite sui generis, in
Other protection
izdelek pomeni zdravilno učinkovino ali kombinacijo zdravilnih učinkovin zdravila.
The provisions of this Sub-section are without prejudice to the right to seek recognition and protection of a geographical indication under the relevant law of a Party.
Vsaka pogodbenica na zahtevo imetnika patenta ali njegovega pravnega naslednika zagotovi obdobje zaščite sui generis za izdelek, ki je zaščiteno z veljavnim osnovnim patentom, če so izpolnjeni naslednji pogoji:
Sub-section D
za dajanje izdelka na trg zadevne pogodbenice kot zdravila je bilo izdano dovoljenje (v tem členu: dovoljenje za promet);
Designs
za izdelek se še ni uporabilo obdobje zaščite sui generis in
Article 20.24
dovoljenje za promet iz pododstavka (a) je prvo dovoljenje za dajanje izdelka na trg zadevne pogodbenice kot zdravila.
Each Party shall make all reasonable efforts to accede to the Geneva Act of the Hague Agreement Concerning the International Registration of Industrial Designs, done at Geneva on 2 July 1999.
Vsaka pogodbenica lahko:
Article 20.25
zagotovi obdobje zaščite sui generis le, če je prvi zahtevek za dovoljenje za promet vložen v razumnem roku, ki ga določi zadevna pogodbenica, in
Relationship to copyright
določi rok za predložitev zahtevka za obdobje zaščite sui generis, in sicer najmanj 60 dni od datuma, na katerega je bilo odobreno prvo dovoljenje za promet.
The subject matter of a design right may be protected under copyright law if the conditions for this protection are met.
Vendar če je prvo dovoljenje za promet odobreno pred odobritvijo patenta, vsaka pogodbenica zagotovi vsaj 60-dnevni rok od odobritve patenta, v katerem se lahko predloži zahtevek za zaščito v skladu s tem členom.
The extent to which, and the conditions under which, such a protection is conferred, including the level of originality required, shall be determined by each Party.
Kadar je izdelek zaščiten z enim osnovnim patentom, začne obdobje zaščite sui generis veljati na koncu zakonitega trajanja tega patenta.
Sub-section E
Kadar je izdelek zaščiten z več patenti, ki se lahko uporabljajo kot osnovni patent, lahko pogodbenica zagotovi le eno obdobje zaščite sui generis, ki začne veljati na koncu zakonitega trajanja osnovnega patenta,
Patents
ki ga v primeru, kadar so vsi patenti, ki bi se lahko uporabljali kot osnovni patent, v lasti istega subjekta, izbere subjekt, ki je vložil zahtevek za obdobje zaščite sui generis, in
Article 20.26
ki ga v primeru, kadar patenti, ki bi se lahko uporabljali kot osnovni patent, niso v lasti istega subjekta, kar je razlog za nasprotujoče si zahtevke za zaščito sui generis, sporazumno izberejo imetniki patentov.
Each Party shall make all reasonable efforts to comply with Articles 1 through 14 and Article 22 of the Patent Law Treaty, done at Geneva on 1 June 2000.
Vsaka pogodbenica zagotovi, da je obdobje zaščite sui generis pet let krajše od obdobja med datumom, na katerega je bil vložen zahtevek za osnovni patent, in datumom prvega dovoljenja za promet.
Article 20.27
Ne glede na odstavek 5 in brez poseganja v možnost podaljšanja obdobja zaščite sui generis s strani pogodbenice kot spodbude ali nagrade za raziskave v zvezi z določeno ciljno populacijo, na primer otroci, trajanje zaščite sui generis ne sme preseči obdobja od dveh do petih let, ki ga določi vsaka pogodbenica.
Sui generis protection for pharmaceuticals
Vsaka pogodbenica lahko določi, da obdobje zaščite sui generis poteče:
basic patent means a patent which protects a product as such, a process to obtain a product or an application of a product, and which has been designated by the holder of a patent that may serve as a basic patent, as the basic patent for the purpose of the granting of sui generis protection; and
če se upravičenec odpove zaščiti sui generis ali
product means the active ingredient or combination of active ingredients of a pharmaceutical product.
če niso plačane vse predpisane upravne pristojbine.
Each Party shall provide a period of sui generis protection in respect of a product that is protected by a basic patent in force at the request of the holder of the patent or his successor in title, provided the following conditions have been met:
Vsaka pogodbenica lahko skrajša obdobje zaščite sui generis sorazmerno s kakršnimi koli neupravičenimi zamudami, ki so posledica neukrepanja predlagatelja po vložitvi vloge za dovoljenje za promet, če je imetnik osnovnega patenta vložnik zahtevka za dovoljenje za promet ali z njim povezana entiteta.
an authorisation has been granted to place the product on the market of that Party as a pharmaceutical product (referred to as ‘marketing authorisation’ in this Article);
V okviru zaščite, ki jo zagotavlja osnovni patent, zaščita sui generis zajema le zdravila, vključena v dovoljenje za promet, in kakršno koli uporabo teh izdelkov kot zdravil, odobreno pred iztekom zaščite sui generis.
the product has not already been the subject of a period of sui generis protection; and
Ob upoštevanju prejšnjega stavka podeljuje zaščita sui generis enake pravice kot osnovni patent ter zanjo veljajo iste omejitve in obveznosti.
the marketing authorisation referred to in subparagraph (a) is the first authorisation to place the product on the market of that Party as a pharmaceutical product.
Ne glede na odstavke 1 do 8, lahko vsaka pogodbenica tudi omeji obseg zaščite, tako da določi izjeme pri izdelavi, uporabi, ponujanju, prodaji ali uvažanju izdelkov za namene izvoza v obdobju zaščite.
Each Party may:
Vsaka pogodbenica lahko prekliče zaščito sui generis na podlagi utemeljitve v zvezi z neveljavnostjo osnovnega patenta, tudi če je navedeni patent potekel pred iztekom zakonitega trajanja patenta ali je bil preklican ali omejen, pri čemer izdelek, za katerega je bila odobrena zaščita, ne ščitijo več zahtevki osnovnega patenta, ali na podlagi utemeljitve v zvezi z umikom dovoljenja ali dovoljenj za promet na zadevnem trgu, ali če je bila zaščita dodeljena v nasprotju z določbami odstavka 2.
provide a period of sui generis protection only if the first application for the marketing authorisation is submitted within a reasonable time limit prescribed by that Party; and
Člen 20.28
prescribe a time limit of no less than 60 days from the date on which the first marketing authorisation was granted for the submission of the request for the period of sui generis protection.
Mehanizmi povezave s patentom v zvezi z zdravili
However, where the first marketing authorisation is granted before the patent is granted, each Party will provide a period of at least 60 days from the grant of the patent during which the request for a period of protection under this Article may be submitted.
Če se pogodbenica zanaša na mehanizme „patentne povezave“, pri čemer je dodelitev dovoljenja za promet (ali uradnega obvestila o skladnosti ali podobni koncepti) za generična zdravila povezana z obstojem patentnega varstva, zagotovi, da imajo vse stranke v postopku enake in učinkovite pravice do pritožbe.
In the case where a product is protected by one basic patent, the period of sui generis protection shall take effect at the end of the lawful term of that patent.
Pododdelek F
In the case where a product is protected by more than one patent that may serve as a basic patent, a Party may provide for only a single period of sui generis protection, which takes effect at the end of the lawful term of the basic patent,
Varstvo podatkov
in the case where all the patents that may serve as a basic patent are held by the same person, selected by the person requesting the period of sui generis protection; and
Člen 20.29
in the case where the patents that may serve as a basic patent are not held by the same person and this gives rise to conflicting requests for the sui generis protection, selected by agreement between the patent holders.
Varstvo nerazkritih podatkov v zvezi z zdravili
Each Party shall provide that the period of sui generis protection be for a period equal to the period which elapsed between the date on which the application for the basic patent was filed and the date of the first marketing authorisation, reduced by a period of five years.
Če pogodbenica kot pogoj za izdajo dovoljenja za promet z zdravili, ki vsebujejo nove kemične sestavine [30] (v tem členu: dovoljenje), zahteva predložitev nerazkritih podatkov o preskusih ali drugih podatkov, ki so potrebni za opredelitev, ali je uporaba zadevnih zdravil varna in učinkovita, te podatke zavaruje pred razkritjem, če je za njihovo pridobitev potrebnega veliko truda, razen kadar je razkritje potrebno za zaščito javnosti ali če se sprejmejo ukrepi za zagotovitev, da so podatki zavarovani pred nepošteno komercialno uporabo.
Notwithstanding paragraph 5 and without prejudice to a possible extension of the period of sui generis protection by a Party as an incentive or a reward for research in certain target populations, such as children, the duration of the sui generis protection may not exceed a period of two to five years, to be established by each Party.
Vsaka pogodbenica v zvezi s podatki v skladu z odstavkom 1, ki so pogodbenici predloženi po datumu začetka veljavnosti tega sporazuma, zagotovi, da:
Each Party may provide that the period of sui generis protection shall lapse:
nihče, razen subjekta, ki je podatke predložil, ne sme brez soglasja tega subjekta uporabiti teh podatkov v podporo vlogi za pridobitev dovoljenja v obdobju najmanj šestih let od datuma, na katerega je pogodbenica izdala dovoljenje subjektu, ki je v ta namen predložil podatke, in
if the sui generis protection is surrendered by the beneficiary; or
pogodbenica ne izda dovoljenja nobenemu subjektu, ki se sklicuje na te podatke v obdobju najmanj osmih let od datuma, na katerega je pogodbenica izdala dovoljenje subjektu, ki je v ta namen predložil podatke, razen če subjekt, ki je te podatke predložil, s tem soglaša.
if any prescribed administrative fees are not paid.
V skladu s tem odstavkom se nobena pogodbenica ne omejuje pri izvajanju skrajšanih postopkov za izdajo dovoljenja za promet s temi izdelki na podlagi študij o bioekvivalenci in biološki uporabnosti.
Each Party may reduce the period of sui generis protection commensurate with any unjustified delays resulting from the inactions of the applicant after applying for the market authorisation, when the holder of the basic patent is the applicant for market authorisation or an entity related to it.
Člen 20.30
Within the limits of the protection conferred by the basic patent, the sui generis protection shall extend only to the pharmaceutical product covered by the marketing authorisation and for any use of that product as a pharmaceutical product that has been authorised before the expiry of the sui generis protection.
Varstvo podatkov v zvezi s fitofarmacevtskimi sredstvi
Subject to the preceding sentence, the sui generis protection shall confer the same rights as conferred by the patent and shall be subject to the same limitations and obligations.
Vsaka pogodbenica določi zahteve glede varnosti in učinkovitosti, preden izda dovoljenje za dajanje fitofarmacevtskega sredstva na trg (v tem členu: dovoljenje).
Notwithstanding paragraphs 1 through 8, each Party may also limit the scope of the protection by providing exceptions for the making, using, offering for sale, selling or importing of products for the purpose of export during the period of protection.
Vsaka pogodbenica zagotovi omejeno obdobje varstva podatkov za poročilo o preskusu ali študiji, ki je prvič predloženo za pridobitev dovoljenja.
Each Party may revoke the sui generis protection on grounds relating to invalidity of the basic patent, including if that patent has lapsed before its lawful term expires or is revoked or limited to the extent that the product for which the protection was granted would no longer be protected by the claims of the basic patent, or on grounds relating to the withdrawal of the marketing authorisation or authorisations for the respective market, or if the protection was granted contrary to the provisions of paragraph 2.
V tem obdobju vsaka pogodbenica zagotovi, da se poročilo o preskusu ali študiji ne bo uporabilo v korist nobenega drugega subjekta, ki si prizadeva pridobiti dovoljenje, razen če je dokazano izrecno soglasje imetnika prvega dovoljenja.
Article 20.28
Predložitev poročila o preskusu ali študiji bi morala biti nujna za pridobitev dovoljenja ali spremembo dovoljenja, da bi se dovolila uporaba na drugih kmetijskih rastlinah.
Patent linkage mechanisms relating to pharmaceutical products
V vsaki pogodbenici traja obdobje varstva podatkov najmanj deset let od datuma izdaje prvega dovoljenja v zadevni pogodbenici v zvezi s poročilom o preskusu ali študiji, na katerem temelji dovoljenje za novo učinkovino, in podatki, na katerih temelji sočasna registracija izdelka za končno uporabo, ki vsebuje učinkovino.
If a Party relies on ‘patent linkage’ mechanisms whereby the granting of marketing authorisations (or notices of compliance or similar concepts) for generic pharmaceutical products is linked to the existence of patent protection, it shall ensure that all litigants are afforded equivalent and effective rights of appeal.
Trajanje varstva se lahko podaljša, da bi se spodbudilo izdajanje dovoljenj za fitofarmacevtska sredstva z majhnim tveganjem in manj pomembne izdelke.
Sub-section F
Vsaka pogodbenica lahko določi tudi zahteve glede varstva podatkov ali finančnega nadomestila za poročilo o preskusu ali študiji, na katerem temelji sprememba ali podaljšanje dovoljenja.
Data Protection
Vsaka pogodbenica določi pravila, da bi se preprečilo podvajanje preskusov na vretenčarjih.
Article 20.29
Vsakega vložnika, ki namerava izvajati preskuse ali študije na vretenčarjih, je treba spodbuditi, da sprejme potrebne ukrepe, s katerimi preveri, ali so bili taki preskusi ali študije že izvedeni ali začeti.
Protection of undisclosed data related to pharmaceutical products
Vsaka pogodbenica bi morala vsakega novega vložnika in vsakega imetnika zadevnih dovoljenj spodbuditi, da si prizadevajo za izmenjavo preskusov in študij, ki vključujejo vretenčarje.
If a Party requires, as a condition for authorising the marketing of pharmaceutical products that utilise new chemical entities [30] (referred to as ‘authorisation’ in this Article) the submission of undisclosed test or other data necessary to determine whether the use of those products is safe and effective, the Party shall protect such data against disclosure, if the origination of such data involves considerable effort, except where the disclosure is necessary to protect the public or unless steps are taken to ensure that the data are protected against unfair commercial use.
Stroški izmenjave poročil o preskusih in študijah se določijo pošteno, pregledno in nediskriminatorno.
Each Party shall provide that for data subject to paragraph 1 that are submitted to the Party after the date of entry into force of this Agreement:
Vložnik krije le stroške za tiste informacije, ki jih mora predložiti za izpolnitev zahtev za dovoljenje.
no person other than the person who submitted them may, without the latter's permission, rely on such data in support of an application for an authorisation during a period of not less than six years from the date on which the Party granted authorisation to the person that produced the data for authorisation; and
Imetnik ali imetniki zadevnega dovoljenja imajo pravico, da prejmejo nadomestilo za pošten delež stroškov, ki so jih imeli s poročilom o preskusu ali študiji, na katerem temelji zadevno dovoljenje, od vložnika, ki se sklicuje na tako poročilo v zahtevku za dovoljenje za novo fitofarmacevtsko sredstvo.
a Party shall not grant an authorisation to any person who relies on such data during a period of not less than eight years from the date on which the Party granted the authorisation to the person that produced the data for the authorisation, unless the person that produced these data provides permission.
Vsaka pogodbenica lahko udeleženim strankam naroči, da kakršno koli vprašanje rešijo na podlagi zavezujoče arbitraže, ki jo ureja pravo pogodbenice.
Subject to this paragraph, there shall be no limitation on either Party to implement abbreviated authorisation procedures for such products on the basis of bioequivalence and bioavailability studies.
Pododdelek G
Article 20.30
Sorte rastlin
Protection of data related to plant protection products
Člen 20.31